Welcome to our dedicated page for Freshpet SEC filings (Ticker: FRPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Freshpet's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Freshpet's regulatory disclosures and financial reporting.
Filer(s) submitted Rule 144 notices reporting proposed sales of common stock. The excerpt lists multiple proposed sales by William B. Cyr, Linda W. Cyr and related trusts, showing individual sale notices dated 05/11/2026 through 05/22/2026 with specific share quantities and dollar amounts.
Freshpet, Inc. director Timothy R. McLevish purchased 3,000 shares of common stock in an open-market transaction on May 18, 2026 at a weighted average price of $48.67 per share. Following this buy, he directly holds 39,879 Freshpet shares.
The shares were acquired in multiple trades at prices ranging from $48.50 to $48.75, with the reported price reflecting the weighted average across these transactions.
Freshpet, Inc. director David Biegger made open-market purchases of a total of 1,000 shares of common stock on May 18, 2026. The trades were executed in three blocks: 690 shares at $48.50, 172 shares at $50.06, and 138 shares at $51.21, each price reported as a weighted average for multiple transactions within stated ranges. Following these purchases, he directly holds 8,488 shares of Freshpet common stock.
Freshpet, Inc. director Jacki Sue Kelley bought additional company stock in the open market. On this transaction date, she acquired 1,000 shares of Freshpet common stock at a price of $48.05 per share. After the purchase, her direct holdings increased to 14,496 shares of common stock.
William B. Cyr and related trusts reported multiple share dispositions under Form 144. The filing lists open-market sales and proposed sales of Common stock on 05/11/2026, 05/13/2026, 05/15/2026, and 05/18/2026, with per-trade values shown in the filing. Transactions involve individual and trust holdings and identify Fidelity Brokerage Services LLC as broker.
FRPT reporting persons including The Linda W Cyr 2020 Irrevocable Trust For Descendants, The William B Cyr 2020 Irrevocable Spousal Trust, and related individuals sold common shares in multiple transactions dated 05/11/2026 through 05/20/2026. Transactions list share counts and gross proceeds per trade, with cash settlement indicated for an option exercise on 05/20/2026.
The filing is a Form 144 notice reporting a proposed sale of 2,950 shares of Common Stock to be sold through Fidelity Brokerage Services on 05/20/2026. The filing also lists multiple open‑market dispositions by related parties during May 2026, including a sale of 42,328 shares on 05/11/2026 for $2,138,691.62.
Freshpet, Inc. CEO William B. Cyr reported a series of option exercises and share sales in Freshpet common stock. On May 15 and May 18, 2026, he exercised options to acquire a total of 168,000 shares at a $10.23 exercise price and sold 94,364 shares in open-market transactions.
The sales occurred at weighted average prices generally between about $47.81 and $51.68 per share. Following these transactions, Cyr holds 185,123 shares of common stock directly, with additional indirect holdings through his spouse and family trusts. The sales were effected under a Rule 10b5-1 trading plan adopted on November 5, 2025, and the options exercised were granted under the company’s 2014 Omnibus Incentive Plan and were fully vested as of December 31, 2020.
FRPT filed a Form 144 reporting proposed sales of Common Stock. The filing lists 42,692 shares to be sold through Fidelity Brokerage Services LLC for proceeds of $2,136,307.68 with a reported shares outstanding figure of 49,142,791 as of 05/18/2026. The excerpt also shows multiple reported dispositions by related parties on 05/11/2026, 05/13/2026, and 05/15/2026, each listing share counts and cash amounts.
The filing is a Form 144 reporting proposed sales of common stock by members of the Cyr family and affiliated trusts. Multiple sales are listed on 05/11/2026, 05/13/2026 and 05/15/2026, with individual transaction sizes and cash proceeds shown.
The excerpt also notes an option granted dated 09/06/2016 and lists Fidelity Brokerage Services LLC as the broker. The transactions are reported as cash sales on the NASDAQ.